Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant (NCT05260268) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
United States360 participantsStarted 2022-12-01
Plain-language summary
Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Liver Transplant Recipient Inclusion Criteria:
* 18 years or older
* Within 3 months of liver transplant
* English or Spanish-speaking
* Home-dwelling\*
* Patient or care partner owns a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone.
* \*The definition of "home" includes hotel or short-term housing. Patients who are going to a rehabilitation or skilled nursing facility (SNF) immediately after transplant may still be recruited if the site-PI/Co-I determines they are likely to be discharged to home within 3 months post-transplant.
Care Partner Inclusion Criteria:
* 18 years or older
* English or Spanish speaking
* Care partner has access to a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone.
Liver Transplant Recipient Exclusion Criteria:
* Liver transplant recipient who speaks neither English nor Spanish
* Any severe uncorrectable vision, hearing, or cognitive impairments that may impede study interviews
Care Partner Exclusion Criteria:
* Care partner who speaks neither English nor Spanish
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.